New hope for a better treatment for childhood cancer

October 13, 2008

Children who are diagnosed with cancer could benefit from better diagnosis and treatment in the future thanks to a new research project involving clinicians and scientists at The University of Nottingham.

Experts at the University are part of the Children's Cancer and Leukaemia Group which has just secured £2.5 million pounds from Cancer Research UK and the Engineering and Physical Sciences Research Council. They will use the money over the next five years to develop and test new ways of scanning childhood tumours in depth to give doctors a more detailed diagnosis. It will also give them a better indication of how to treat the tumour and whether it will respond to new drugs.

The grant is part of a nationwide investment of £50m to establish four large cancer imaging centres and five cancer imaging research programmes. The cancer imaging initiative will help the development and introduction of the latest imaging technologies to help advances in basic and clinical cancer research.

Cancer is the most common cause of death from disease in children with most cases involving solid tumours. Around 1,500 children are diagnosed every year in the UK. At present conventional Magnetic Resonance Imaging (MRI) is the usual technique for scanning of patients but it provides limited, mainly anatomical, information. This research project will look at how more accurate ways of analysing tumours, using Magnetic Resonance Spectroscopy (MRS) and Diffusion/Perfusion MRI of tumour tissue, can be better and more widely used by doctors treating children with cancer. Diffusion MRI measures the molecular mobility of water in tissue, while perfusion MRI measures the rate at which blood is delivered to tissue. It gives a much clearer picture of the nature and composition of the tumour in a non-invasive way. Treatment can then be more accurately tailored.

The Children's Cancer and Leukaemia Group, funded by Cancer Research UK, runs clinical trials for paediatric cancer at specialist centres across the UK. It has formed a Functional Imaging Group to develop the use of the techniques in treating children with brain tumours. This significant new grant means the group's research can be extended to examine other Magnetic Resonance methods and their use on tumours in the rest of the body. The information will be disseminated and evaluated through the group's established clinical trials network in the UK. This will make sure as many children as possible benefit from the latest MRI technology.

Professor of Paediatric Neuro-Oncology, Richard Grundy, from Nottingham University Medical School, said: "We all delighted that we have won this grant. Fortunately cancer in children is relatively uncommon compared to adults, reinforcing the need to develop and test the role of new techniques or treatments as a collaborative effort. This important grant from Cancer Research UK and the EPSRC allows us to investigate advanced Magnetic Resonance imaging to improve our understanding and treatment of childhood cancer. This funding and recognition of NUH should also help our aspirations locally to develop an imaging centre dedicated for children as part of the new Nottingham Children's Hospital development."

Professor Herbie Newell, Director of Translational Research at Cancer Research UK, said: "Imaging is an invaluable tool in the fight against cancer. Being able to see what's happening inside cells is vitally important in understanding how treatments are currently working and the best ways to improve them."
-end-


University of Nottingham

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.